What Secy. Raimondo’s China Trip Will Mean for U.S. Relations with Beijing, and Is the IPO Pipeline Opening Back Up? 8/28/23
CNBC's "Fast Money"
00:00
Biden Administration's Medicare Price Negotiations and Pharmaceutical Industry Challenges
Discussion on the upcoming announcement of Medicare part and deep price negotiations by the Biden administration, including the selection of drugs from Pfizer, Eli Lilly, Merck, Abby, and Bristol Myers. Analysis of the political and complicated nature of the negotiations, lawsuits against the government, challenges in pricing and lobbying efforts in the pharmaceutical industry, and potential trading opportunities.
Play episode from 20:56
Transcript
